stockrowThe Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- +23.6%
- Free cash flow
- +89.2%
- Total debt
- +39.2%
Quarter to September 2026, against a year earlier
Follow ENSG
Alert me
The Ensign Group, Inc. (ENSG) Return on equity
The Ensign Group, Inc.'s return on equity over the twelve months to 30 September 2026 was 17.0%, up 0.2 percentage points from fiscal 2025 (16.9%). Over the past ten years it has ranged from 8.43% (fiscal 2017) to 23.1% (fiscal 2020); the current reading is higher than 55% of that period. That is above the Medical Care Facilities industry median of 5.03% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 16.9% | (0.97) |
| FY2024 | 17.9% | 2.60 |
| FY2023 | 15.3% | (4.54) |
| FY2022 | 19.8% | (1.37) |
| FY2021 | 21.2% | (1.97) |
| FY2020 | 23.1% | 5.56 |
| FY2019 | 17.6% | 0.81 |
| FY2018 | 16.8% | 8.33 |
| FY2017 | 8.43% | (2.84) |
| FY2016 | 11.3% | (4.92) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| CON Concentra Group Holdings Parent, Inc. compare | 47.9% |
| UHS Universal Health Services, Inc. compare | 40.0% |
| CHE Chemed Corporation compare | 29.1% |
| PACS PACS Group, Inc. compare | 26.5% |
| EHC Encompass Health Corporation compare | 19.4% |
| ENSG The Ensign Group, Inc. | 17.0% |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 5.90% |
| LFST LifeStance Health Group, Inc. compare | 4.82% |
| DVA DaVita Inc. compare | −277.7% |
| Medical Care Facilities industry median | 5.03% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on ENSG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement